As Per the Report, the Size of the Latin America Platelet Aggregation Devices Market is valued at USD 33.47 million in 2022 and is expected to grow at a CAGR of 18.7%, to reach USD 78.88 million by 2027 during the forecast period 2022 to 2027.
Factors such as the high throughput of pharmaceutical companies to select targets for the development of antiplatelet drugs, the baseline test to protect patients at high risk of bleeding before surgery, the increase in platelet disorders such as thrombocythemia, the growing acceptance of treatment platelet counts in cancer patients are driving the growth of the Latin America platelet aggregation devices market.
Furthermore, besides the continued advancements of the platelet aggregometer and the increasing prevalence of chronic diseases such as arthritis, asthma is facilitating the growth of the Latin America platelet aggregation devices market. In addition, the increase in the number of older adults around the world is also stimulating the growth of Latin American platelet aggregation devices.
Cardiovascular diseases are affecting almost all nations. According to the CDC, each year, more than 800,000 people die of heart disease. And coronary artery disease is responsible for more than 500,000 deaths per year across the world. In addition, about 525,000 people have the first heart attack, and 550,000 have a recurrent heart attack each year.
Antiplatelet therapy is a treatment widely used to reduce the risk of major cardiovascular events in patients with cardiovascular disease. However, high residual platelet reactivity in patients on antiplatelet therapy leads to thromboembolic complications. Functional tests for platelets are needed for antiplatelet therapies to avoid the complications above; all these factors will drive the growth of Latin American platelet aggregation devices.
The number of specialized laboratories and hospitals in developing countries such as Peru, Chile, Puerto Rico, etc., is increasing. Growing healthcare infrastructure expenditure drives the technical use of advanced systems in laboratories and hospitals for quicker results. The demand for advanced techniques is also increasing in many academic and pharmaceutical companies for research studies to help understand the interaction of platelets with vascular surfaces and their physiology behind it and for screening antithrombotic factors to discover new antiplatelet drug targets.
However, some of the constraints on this projected growth will attribute to the high purchase cost, limited use, and limited reach at the end-user level. Additionally, strict government rules and a lack of medical reimbursement will hamper the market's growth shortly.
This research report on the Latin America Platelet Aggregation Devices Market has been segmented and sub-segmented into the following categories
By End User:
Geographically, the Brazil platelet aggregation devices market dominates the Latin America platelet aggregation devices market, followed by Mexico platelet aggregation devices market, as the significant manufacturers of platelet aggregation devices are domiciled in these regions and have the majority of their operations in local, regional markets. However, Argentina is also one of the significant lucrative markets for these diagnostic devices for epidemic diseases such as dengue and malaria is prevalent in this region.
Many international companies are looking to expand their products to emerging markets due to the huge as a result of the emergence of a large patient base in countries like Brazil and Mexico; In Mexico, health spending is expected to increase due to the growing aging of the population, growing healthcare awareness, the rising incidence of chronic diseases and the availability of healthcare services.
KEY MARKET PLAYERS
Noteworthy Companies leading the Latin America Platelet Aggregation Devices Market are Accriva Diagnostics, Helena Laboratories Corporation, BioData Corporation, Haemonetics Corporation, Siemens AG, Sysmex Corporation, Sentinel CH. S.p.A., Tem Group and Aggredyne, Inc.,
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.4 Consumables and Accessories
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2.2 Clinical Applications
188.8.131.52 Cardiovascular Applications
184.108.40.206 Orthopedic Applications
220.127.116.11 Other Clinical Applications
5.2.3 Research Applications
5.2.4 Y-o-Y Growth Analysis, By Application
5.2.5 Market Attractiveness Analysis, By Application
5.2.6 Market Share Analysis, By Application
5.3.2 Standalone Hospitals
5.3.3 Diagnostic Laboratories
5.3.4 Research and Academic Institutes
5.3.5 Other End Users
5.3.6 Y-o-Y Growth Analysis, By End User
5.3.7 Market Attractiveness Analysis, By End User
5.3.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Product
126.96.36.199 By End User
6.1.4 Market Attractiveness Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Product
220.127.116.11 By Application
18.104.22.168 By End User
6.1.5 Market Share Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Product
188.8.131.52 By Application
184.108.40.206 By End User
6.5 Rest of Latin America
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Helena Laboratories Corporation
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Haemonetics Corporation
8.3 Siemens AG
8.4 Sysmex Corporation
8.5 Accriva Diagnostics
8.6 Sentinel CH. S.p.A.
8.7 Bio/Data Corporation
8.8 Tem Group
8.9 Aggredyne, Inc.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.